Yaqi Ouyang1, Yuhui Wang2, Baoyan Liu2, Xiaochun Ma3, Renyu Ding4. 1. Department of Intensive Care Unit, Xiehe Hospital affiliated to Tongji Medical College, Huazhong University of Science and Technology,Jiefang Avenue 1277, Wuhan 430000, , Hubei Province, PR China. 2. Department of Intensive Care Unit, The First Hospital of China Medical University, Nanjing Bei Street 155, Shenyang 110001, Liaoning Province, PR China. 3. Department of Intensive Care Unit, The First Hospital of China Medical University, Nanjing Bei Street 155, Shenyang 110001, Liaoning Province, PR China. Electronic address: xcma2972@sina.com. 4. Department of Intensive Care Unit, The First Hospital of China Medical University, Nanjing Bei Street 155, Shenyang 110001, Liaoning Province, PR China. Electronic address: renyuding@126.com.
Abstract
PURPOSE: Abnormal platelet activation plays an important role in the development of sepsis. The effect of antiplatelet drugs on the outcome of patients with sepsis remains unclear. This meta-analysis aimed to determine the effect of antiplatelet drugs on the prognosis of patients with sepsis. MATERIALS AND METHODS: PubMed, Cochrane Library, CBM, and Embase were searched for all related articles published from inception to April 2018. The primary end point was mortality. Adjusted data were used and statistically analysed. RESULTS: Ten cohort studies were included. The total number of patients with sepsis was 689,897. Data showed that the use of antiplatelet drugs could effectively reduce the mortality of patients with sepsis (odds ratio (OR) = 0.82, 95% CI: 0.81-0.83, p < 0.05). Seven studies used aspirin for antiplatelet therapy, and subgroup analysis showed that aspirin effectively reduced ICU or hospital mortality in patients with sepsis (OR = 0.60, 95% CI: 0.53-0.68, p < 0.05). A subgroup analysis on the timing of anti-platelet drug administration showed that antiplatelet drugs can reduce mortality when administered either before (OR = 0.78, 95% CI: 0.77-0.80) or after sepsis (OR = 0.59, 95% CI: 0.52-0.67). CONCLUSIONS: Antiplatelet drugs, particularly aspirin, could be used to effectively reduce mortality in patients with sepsis.
PURPOSE: Abnormal platelet activation plays an important role in the development of sepsis. The effect of antiplatelet drugs on the outcome of patients with sepsis remains unclear. This meta-analysis aimed to determine the effect of antiplatelet drugs on the prognosis of patients with sepsis. MATERIALS AND METHODS: PubMed, Cochrane Library, CBM, and Embase were searched for all related articles published from inception to April 2018. The primary end point was mortality. Adjusted data were used and statistically analysed. RESULTS: Ten cohort studies were included. The total number of patients with sepsis was 689,897. Data showed that the use of antiplatelet drugs could effectively reduce the mortality of patients with sepsis (odds ratio (OR) = 0.82, 95% CI: 0.81-0.83, p < 0.05). Seven studies used aspirin for antiplatelet therapy, and subgroup analysis showed that aspirin effectively reduced ICU or hospital mortality in patients with sepsis (OR = 0.60, 95% CI: 0.53-0.68, p < 0.05). A subgroup analysis on the timing of anti-platelet drug administration showed that antiplatelet drugs can reduce mortality when administered either before (OR = 0.78, 95% CI: 0.77-0.80) or after sepsis (OR = 0.59, 95% CI: 0.52-0.67). CONCLUSIONS: Antiplatelet drugs, particularly aspirin, could be used to effectively reduce mortality in patients with sepsis.
Authors: Aitana Braza-Boïls; Temo Barwari; Clemens Gutmann; Mark R Thomas; Heather M Judge; Abhishek Joshi; Raimund Pechlaner; Manu Shankar-Hari; Ramzi A Ajjan; Ian Sabroe; Robert F Storey; Manuel Mayr Journal: Int J Mol Sci Date: 2020-04-21 Impact factor: 5.923
Authors: Nader Yatim; Jeremy Boussier; David M Smadja; Benjamin Terrier; Richard Chocron; Jérôme Hadjadj; Aurélien Philippe; Nicolas Gendron; Laura Barnabei; Bruno Charbit; Tali-Anne Szwebel; Nicolas Carlier; Frédéric Pène; Célia Azoulay; Lina Khider; Tristan Mirault; Jean-Luc Diehl; Coralie L Guerin; Frédéric Rieux-Laucat; Darragh Duffy; Solen Kernéis Journal: Ann Intensive Care Date: 2021-07-17 Impact factor: 6.925
Authors: Michael Joseph Cryer; Serdar Farhan; Christoph C Kaufmann; Bernhard Jäger; Aakash Garg; Prakash Krishnan; Roxana Mehran; Kurt Huber Journal: Clin Appl Thromb Hemost Date: 2022 Jan-Dec Impact factor: 2.389